Cytochroma Inc.
logo BDC

Cytochroma Inc.

Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).

Investment year:  2002
Industry sector:  Biotechnology
Region:  Ontario
Follow Cytochroma Inc.

Recent news

OPKO Health Completes Acquisition of Two Phase 3 Products

Learn More
BDC Venture Capital Partner

Ela Borenstein

Program Director